Dry Eye Treatment

Dry eye occurs when the tear film is unstable, the eyes produce too few tears, or the tears evaporate too quickly due to factors such as meibomian gland dysfunction, chronic inflammation, or systemic conditions. Environmental triggers, prolonged screen use, contact lens wear and certain medications can worsen symptoms and contribute to disease progression. Identifying the specific cause is critical because treatments target different mechanisms rather than only relieving surface symptoms.

Diagnosis begins with a detailed medical and symptom history followed by targeted testing to evaluate tear quality, tear volume and the health of the ocular surface. Providers may use specialized imaging to visualize meibomian gland structure, perform staining to detect surface damage and measure tear osmolarity to assess tear film stability. Combining these objective tests with clinical exam findings allows for a precise, individualized treatment plan.

Common symptoms that warrant an evaluation include persistent grittiness, burning, redness, watery eyes and a sensation of eye fatigue that worsens by the end of the day. Patients often report fluctuating or blurred vision, sensitivity to light and discomfort with reading or using digital devices. If over-the-counter drops provide only temporary relief or symptoms interfere with daily activities, you should seek a professional assessment.

An evaluation is particularly important if contact lenses become uncomfortable, if symptoms fail to improve with basic measures, or if you have underlying conditions that increase risk, such as autoimmune disease. Early assessment helps identify treatable causes like meibomian gland dysfunction before chronic changes develop. Timely diagnosis increases the chance of restoring comfort and protecting ocular surface health.

A Visual Affair combines a comprehensive symptom review with advanced diagnostic tools to pinpoint the root causes of dry eye rather than treating only surface symptoms. Our assessments go beyond a standard slit-lamp exam to include specialized imaging of the meibomian glands, tear film evaluation and objective measures of ocular surface health. This layered approach clarifies whether the problem stems from gland dysfunction, aqueous deficiency, inflammation or a combination of factors.

By identifying the specific drivers of your symptoms, clinicians can design a personalized treatment plan that pairs in-office therapies, prescription medications and targeted home care as needed. The goal is to treat the underlying dysfunction and reduce reliance on short-acting drops when appropriate. Follow-up testing then monitors response and guides adjustments to therapy.

In-office therapies such as Intense Pulsed Light (IPL) and radio frequency (RF) treatment address inflammation and improve meibomian gland function to restore a healthier tear film. IPL uses controlled light pulses to reduce abnormal blood vessels and inflammatory mediators at the eyelid margin, which can decrease ocular surface inflammation and improve oil secretion. Radio frequency therapy delivers gentle, targeted heat to the eyelids to liquefy thickened meibum and promote more effective gland expression.

Both treatments are typically performed as a series of sessions and are often combined with manual gland expression, lubricating care and anti-inflammatory medications when indicated. These modalities aim to treat underlying gland dysfunction and provide more durable relief than lubricating drops alone. Safety protocols and pre-treatment assessments ensure each therapy is appropriate for the individual patient.

Candidates for IPL or RF therapy typically include patients with moderate to severe meibomian gland dysfunction, chronic evaporative dry eye or persistent symptoms despite standard conservative care. An in-person evaluation is necessary to confirm the diagnosis and to identify any contraindications such as active skin infection, certain photosensitive conditions or other medical concerns. Suitability also depends on the pattern of gland dysfunction and the overall health of the ocular surface.

During the consultation the clinician will review your medical history, examine the eyelids and glands and may perform diagnostic imaging to determine likely benefit. If either therapy is recommended, the team will discuss the expected course, possible side effects and a follow-up plan to track improvement. Alternative or adjunctive treatments are offered when IPL or RF are not appropriate.

Your dry eye evaluation will begin with a focused history about symptoms, lifestyle factors and any relevant medical or medication history. The clinician will perform a slit-lamp exam and targeted tests that may include tear film assessment, ocular surface staining and imaging of the meibomian glands to gather objective data. These tests are noninvasive and help determine the exact mechanism driving your symptoms.

If an in-office therapy is appropriate, the provider will explain the procedure, expected sensations during treatment and a recommended schedule for follow-up visits. Many procedures are performed in the office with topical comfort measures and require minimal downtime, although individual experiences vary. Before any treatment begins you will receive personalized instructions and have the opportunity to ask questions about next steps.

Improvement timelines vary by individual and by the type of therapy administered, but many patients notice measurable benefits within a few weeks of starting a recommended treatment course. Some therapies require multiple sessions spaced over several weeks to achieve optimal results, while adjunctive home care and prescription treatments can accelerate or sustain improvement. The degree and speed of symptom relief depend on the severity of gland dysfunction and how closely patients follow the overall care plan.

Clinicians typically schedule follow-up visits to assess response and adjust therapy based on objective findings and symptom reports. Maintenance treatments or periodic repeat procedures may be recommended to preserve gland function over time. Realistic expectations and ongoing communication with your provider support the best long-term outcomes.

Home care and lifestyle adjustments are essential complements to in-office therapies and often determine long-term success. Recommended measures include consistent lid hygiene with warm compresses, regular lid cleaning to remove debris, blinking exercises during screen use and attention to environmental factors like humidity and air flow. These practices help maintain improved gland function and reduce the frequency of symptom recurrence.

Clinicians may also recommend prescription eye drops, topical anti-inflammatory agents or changes to contact lens wear as part of a comprehensive plan. Dietary considerations, sleep habits and medication reviews can further support ocular surface health. A coordinated approach that combines professional treatment with disciplined home care gives the best chance of sustained relief.

Yes, contact lens wearers commonly experience dry eye and can often benefit from targeted evaluation and treatment to improve comfort and wear time. Management may include optimizing lens type, fit and replacement schedule in addition to therapies that address underlying tear film and eyelid gland issues. Treating meibomian gland dysfunction and ocular surface inflammation can markedly improve lens tolerance for many patients.

During treatment courses that involve in-office procedures or certain medications, temporary changes to lens use may be advised to promote healing and comfort. Your clinician will provide specific guidance about when to resume contact lens wear and whether alternative lens options or specialty lenses could help long-term. Coordinated care ensures both ocular surface health and successful lens use when appropriate.

Follow-up care is important to monitor treatment response, assess objective improvements and adjust the plan as needed to achieve and maintain symptom control. Initial reassessments are typically scheduled a few weeks after therapy begins, with subsequent visits based on progress and clinical findings. Some patients require periodic maintenance treatments or ongoing prescription therapies to sustain gland function and tear film stability.

Long-term management commonly includes continued lid hygiene, environmental modifications and adherence to any prescribed topical medications. Regular re-evaluation helps detect recurrence early and allows the care team to intervene before symptoms become severe. A proactive maintenance strategy supports long-lasting comfort and ocular surface health.